Chronic Myeloproliferative Disorders Completed Phase Trials for Dapsone (DB00250)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00993694Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone